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ABSTRACT In eukaryotes, glycosylation plays a role in proteome stability, protein
quality control, and modulating protein function; however, similar studies in bacteria
are lacking. Here, we investigate the roles of general protein glycosylation systems
in bacteria using the enteropathogen Campylobacter jejuni as a well-deﬁned exam-
ple. By using a quantitative proteomic strategy, we were able to monitor changes in
the C. jejuni proteome when glycosylation is disrupted. We demonstrate that in C. je-
juni, N-glycosylation is essential to maintain proteome stability and protein quality
control. These ﬁndings guided us to investigate the role of N-glycosylation in modu-
lating bacterial cellular activities. In glycosylation-deﬁcient C. jejuni, the multidrug ef-
ﬂux pump and electron transport pathways were signiﬁcantly impaired. We demon-
strate that in vivo, fully glycosylation-deﬁcient C. jejuni bacteria were unable to
colonize its natural avian host. These results provide the ﬁrst evidence of a link be-
tween proteome stability and complex functions via a bacterial general glycosylation
system.
IMPORTANCE Advances in genomics and mass spectrometry have revealed several
types of glycosylation systems in bacteria. However, why bacterial proteins are modi-
ﬁed remains poorly deﬁned. Here, we investigated the role of general N-linked gly-
cosylation in a major food poisoning bacterium, Campylobacter jejuni. The aim of
this study is to delineate the direct and indirect effects caused by disrupting this
posttranslational modiﬁcation. To achieve this, we employed a quantitative pro-
teomic strategy to monitor alterations in the C. jejuni proteome. Our quantitative
proteomic results linked general protein N-glycosylation to maintaining proteome
stability. Functional analyses revealed novel roles for bacterial N-glycosylation in
modulating multidrug efﬂux pump, enhancing nitrate reduction activity, and pro-
moting host-microbe interaction. This work provides insights on the importance of
general glycosylation in proteins in maintaining bacterial physiology, thus expanding
our knowledge of the emergence of posttranslational modiﬁcation in bacteria.
KEYWORDS glycosylation, host-microbe interaction, microbial physiology,
pathogenesis, proteomics
Glycosylation is a prevalent protein posttranslational modiﬁcation found in nature.In eukaryotes, the attachment of glycans to proteins has been shown to play a
central role in modulating protein folding, stability, and signaling (1). Advances in
genomics and mass spectrometry have revealed several types of glycosylation systems
in bacteria. Among prokaryotes, general glycosylation systems have been reported in
pathogenic bacteria, including Campylobacter jejuni (2), Neisseria gonorrhoeae (3), Burk-
holderia cepacia (4), as well as commensal bacteria such as Bacteroides fragilis (5),
indicating their abundance across the kingdom. However, the reasons why bacterial
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proteins are speciﬁcally modiﬁed remains poorly deﬁned, particularly among general
protein glycosylation systems.
Genetic and biochemical studies have revealed that in C. jejuni, the N-
oligosaccharyltransferase PglB is responsible for decorating at least 50 proteins in the
C. jejuni cell with the heptasaccharide GalNAc-1,4-GalNAc-[Glc1,3-]GalNAc-1,4-
GalNAc-1,4-GalNAc-1,3-diBacNAc-1, where GalNAc is N-acetylgalactosamine, Glc is
glucose, and diBacNAc is 2,4-diacetamido-2,4,6-trideoxyglucopyranose. This glycostruc-
ture is linked to the asparagine residue in the acceptor sequon D/E-X1-N-X2-S/T where
X1 and X2 can be any amino acid except proline (6). Comparative genomic studies have
revealed the conservation of general N-glycosylation gene clusters across the Campy-
lobacter genus (7). Mutagenesis studies demonstrated that disruption of the
N-glycosylation pathway led to pleiotropic effects in C. jejuni. These effects include a
substantial decrease in bacterial adherence and invasion capability of INT 407 intestinal
epithelial cells (8), a decrease in chicken colonization (9), and a reduction in compe-
tence (10). Similar ﬁndings have also been reported in other bacteria where inactivation
of their corresponding general glycosylation systems resulted in a disruption in cellular
physiology and a reduction in virulence (4, 5). These combined consequences were
anticipated to be due to direct or indirect disruptions of several cellular processes in
glycosylation-deﬁcient strains. However, these studies did not address what perturba-
tions may be occurring to the bacterial cell when glycosylation is no longer possible. To
answer this question, we developed a platform to investigate the role of general
N-linked glycosylation systems in prokaryotes, using C. jejuni as a model example.
We employed tandem mass tag (TMT) isobaric 6plex labeling quantitative proteom-
ics on wild-type and glycosylation-deﬁcient strains. Analysis of a glycosylation-deﬁcient
strain, revealed chaperones and stress-related proteins are more abundant, indicating
a central alteration in bacterial cellular activities. Thus, contrary to current understand-
ing, the loss of glycosylation predominantly has a mass effect on the C. jejuni proteome,
rather than being restricted exclusively to proteins modiﬁed by glycosylation. Pheno-
typically this resulted in reduction in multidrug efﬂux pump activity as well as impair-
ment in nitrate reductase activity. Furthermore, we demonstrate that general
N-glycosylation plays an important role in host-microbe interactions in the chicken
colonization model. This study provides deeper insights on the role of a general
N-glycosylation system in bacteria, demonstrating that protein posttranslational mod-
iﬁcation is critical to a plethora of bacterial cellular activities.
RESULTS
N-glycosylation is essential for proteome stability. Quantitative proteomics
serves as a tool to understand alterations in proteomes resulting from disruption of
gene(s). To provide deeper insights into the role of the general glycosylation system in
prokaryotes, we employed a mass spectrometry-based quantitative proteomic strategy
to monitor differential protein abundance in glycosylation-deﬁcient C. jejuni and com-
pared this to wild-type bacteria. Proteins from both C. jejuni strains were reduced,
alkylated, digested, and then labeled by tandem mass tag (TMT) 6plex isobaric labels to
allow multiplex quantiﬁcation for multiple samples. In total, 1,052 proteins out of 1,623
proteins were identiﬁed by matching peptides to the C. jejuni 11168 curated proteome.
Proteins were quantitatively compared across the samples (6plex) and then ﬁltered at
95% CI. After signiﬁcance ﬁltering, 502 proteins were found to be statistically different
in the two strains; 120 proteins were more abundant and 382 proteins were less
abundant in C. jejuni pglB::aphA lacking the oligosaccharyltransferase compared to the
wild-type strain (Fig. 1A to C) (11, 12). Surprisingly, chaperones and proteases were
found in signiﬁcantly higher abundance in the glycosylation-deﬁcient C. jejuni (Fig. 1C).
Among these chaperones, we detected GroL, a periplasmic chaperone that binds to
unfolded and partially folded proteins promoting folding (13), HtpG, a chaperone
involved in binding to aggregated proteins and protecting the cell against environ-
mental stresses (14), and Cj0694, a peptidyl-prolyl-cis/trans isomerase (PPIase) that
interacts with the Sec translocon and promotes folding of polypeptides emerging from
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FIG 1 Quantitative comparison of wild-type C. jejuni and C. jejuni pglB::aphA proteomes. (A) Selected proteins that are statistically differentially expressed
in wild-type C. jejuni and C. jejuni pglB::aphA proteomes. Proteins were analyzed by Perseus and presented according to their fold change with 95% CI. (B)
(Continued on next page)
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the translocon (15, 16). Protein degradation pathway proteins were also signiﬁcantly
highly abundant, notably HtrA, which is a multifunctional protein that plays a central
role in proteolytically cleaving misfolded proteins as well as preventing aggregation of
nonnative proteins (15, 17). This observation correlates with a signiﬁcant reduction in
the abundance of HspR in the same strain. HspR is a negative transcriptional regulator
of chaperone-encoding genes such as clpB, dnaK, and groLS. Disruption of hspR
enhanced thermotolerance in C. jejuni (18). Cytoplasmic chaperones and proteases such
as ClpB, Lon, Trigger factor (Tig), and HslU that are reported to be involved in various
arrays of protein quality mechanisms from assisting protein folding to protein degra-
dation were also found to be differentially, but not statistically signiﬁcantly, abundant
in C. jejuni pglB::aphA (19) (Fig. 1C). These results indicate that disrupting N-linked
glycosylation leads to a global alteration in the abundance of protein quality control
machineries. The high abundance of chaperones and proteases suggests a potential
misfolding of proteins and a rise in protein aggregation in glycosylation-deﬁcient C.
jejuni.
Alteration in glycoprotein abundance in glycosylation-deﬁcient C. jejuni. Bio-
chemical and biophysical studies of glycoproteins have revealed that N-linked glycans
play a role in stabilizing proteins (20), promoting protein folding (21), and preventing
protein aggregation (22). Enrichment analysis of the glycoproteome of C. jejuni has
revealed 53 proteins to be decorated by the C. jejuni heptasaccharide GalNAc-1,4-
GalNAc-[Glc1,3-]GalNAc-1,4-GalNAc-1,4-GalNAc-1,3-diBacNAc covalently linked to
the asparagine residue in D/E-X1-N-X2-S/T where X1 and X2 can be any amino acid
except proline (6, 23). Our quantitative proteomic approach managed to detect and
correctly evaluate 35 glycoproteins in the samples. Out of the 35 glycoproteins de-
tected, only 8 proteins (22.8%) were more abundant in glycosylation-deﬁcient C. jejuni
and 6 proteins (17.1%) were found to be unchanged. Interestingly, 21 proteins (60%)
were found to be less abundant in C. jejuni pglB::aphA. It is unclear whether the low
abundance of these proteins is due to misfolding/degradation of the proteins or is a
consequence of global defects resulting from disruption of the N-linked glycosylation
pathway. To gain more insights into the role of the C. jejuni heptasaccharide in
promoting protein stability, we sought to study the functional activity of glycoproteins
in C. jejuni.
N-glycosylation modulates multidrug efﬂux pump activity. A difﬁculty in study-
ing the role of general glycosylation systems in bacteria is that the modiﬁed proteins
often have no known function. Using a genetically tractable bacterium that modiﬁes
proteins with predictable phenotypes could help to assign more deﬁnitively the role of
glycosylation. Only two protein assemblies out of the 35 detected glycoproteins in our
study on C. jejuni have known phenotypes (6, 24, 25). CmeABC shares amino acid
sequence homology and similar molecular architecture with other tripartite resistance-
nodulation-division (RND) type multidrug efﬂux pumps in other Gram-negative bacteria
(26). Acting as the major multidrug efﬂux pump in C. jejuni, CmeABC plays an important
role in antibiotic resistance and host colonization (27). The tripartite RND of C. jejuni is
a molecular assembly of CmeB, an inner membrane multidrug transport protein, CmeA,
a periplasmic fusion protein, and CmeC, an outer membrane-associated protein chan-
nel (24), where all three complex components were found to be glycosylated (6). Our
bioinformatic analysis showed the presence of two glycosylation sequons at each
protein (CmeA, CmeB, and CmeC) of the CmeABC assembly. In C. jejuni pglB::aphA,
CmeA was found to be 0.8-fold less abundant, while no change was seen in the levels
of CmeB and CmeC compared to the wild type (Fig. 2A). To investigate the role of the
FIG 1 Legend (Continued)
Volcano plot analysis of signiﬁcantly abundant proteins. The log10 (Student’s t test) is plotted against log2 mean fold change of C. jejuni pglB::aphA,P C.
jejuni, WT. The nonaxial horizontal line denotes P  0.05, while the nonaxial vertical lines denote 0.5- and 2-fold changes, respectively. The volcano plot
was generated using PANDA-view (12). (C) Differential expression of chaperones and proteases in wild-type C. jejuni and C. jejuni pglB::aphA. Data are from
three biological replicates. The error bars represent standard deviations. Values that are signiﬁcantly different by Student’s t test are indicated by asterisks
as follows: *, P  0.05; **, P  0.01.
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heptasaccharide in multidrug resistance, we sought to assess the antibiotic resistance
proﬁle of C. jejuni and glycosylation-deﬁcient C. jejuni. A C. jejuni cmeB::aphA mutant
was constructed and showed a substantial increase in antibiotic sensitivity. In
glycosylation-deﬁcient C. jejuni, a 100% increase in sensitivity against ampicillin, eryth-
FIG 2 Differential expression and functional analysis of CmeABC in C. jejuni. (A) Differential expression of CmeABC in wild-type C. jejuni and C. jejuni pglB::aphA.
Data are from three biological replicates, and error bars represent standard deviations. Data were analyzed by Student’s t test. (B) Ethidium bromide
accumulation test in C. jejuni strains. Thirty milliliters of brucella broth was separately inoculated with overnight cultures of C. jejuni (black circles), C. jejuni
cmeB::aphA (open circles), and C. jejuni pglB::aphA (gray squares) to an OD600 of 0.1. Cells were grown until an OD600 of 0.4 to 0.5 was reached, spun down,
washed, and resuspended to an OD600 of 0.2 in 10 mM sodium phosphate buffer (pH 7). Cells were then incubated in a VAIN for 15 min at 37°C, and then
ethidium bromide was added to a ﬁnal concentration of 0.2 mg/ml. Fluorescence was read at excitation and emission for 20 min at 37°C. (B) Ethidium bromide
accumulation in C. jejuni strains throughout 20 min. (C) Ethidium bromide accumulation in C. jejuni strains at 15 min. The data are means for three biological
replicates, two technical replicates each, and the error bars represent standard deviations. Signiﬁcance was calculated using one-way ANOVA test with multiple
comparison and indicated by asterisks as follows: **, P  0.01; ***, P  0.001; ****, P  0.0001.
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romycin, tetracycline, and ciproﬂoxacin was observed compared to the wild type (see
Table S1 in the supplemental material). The results may be due to a defect in CmeABC
multidrug efﬂux leading to an accumulation of antibiotics. In order to gain further
insights on the effect of glycosylation on CmeABC activity, we used the ﬂuorescent
intercalating agent ethidium bromide in an accumulation assay that enables monitor-
ing of efﬂux pump activity in real time. Ethidium bromide accumulation in C. jejuni
cmeB::aphA was 15% higher (P 0.0016) than in the wild-type strain. This result is in
agreement with the antibiotic susceptibility tests. The ethidium bromide accumulation
in C. jejuni pglB::aphA was 27.5% higher than in the wild type (P 0.0001) (Fig. 2B and
C). The results show that the effect of glycosylation on C. jejuni ethidium bromide
accumulation kinetics is more detrimental than inactivation of the major multidrug
efﬂux complex. Our results demonstrate the pivotal role of the heptasaccharide in efﬂux
activity and subsequent multidrug resistance in C. jejuni.
Nitrite production impairment in glycosylation-deﬁcient C. jejuni. To analyze
whether the loss of glycosylation affects other complex assemblies in C. jejuni, we
interrogated the activity of NapAB for nitrite production. NapAB is a two-subunit
periplasmic nitrate reductase enzyme that is responsible for the reduction of nitrate to
nitrite. NapAB consists of a twin arginine translocation substrate; NapA is a 90-kDa
catalytic bis-molybdenum guanosine dinucleoside (MGD) cofactor binding enzyme,
while NapB is a 16-kDa diheme C-type cytochrome glycoprotein (6, 25). Inactivation of
napA in C. jejuni results in reduction in chicken colonization (28). Mass spectrometric
analysis of the C. jejuni glycoproteome demonstrated that NapB is glycosylated at 50N;
however, there is no experimental evidence that NapA is a glycoprotein (6). Our
quantitative proteomic analysis unexpectedly revealed a 1.7 0.2-fold increase in both
NapA and NapB levels in C. jejuni pglB::aphA compared to the wild type (Fig. 3A).
Interestingly, there was no change in abundance in twin arginine translocase (TatA) or
the NapA-accompanying chaperone NapD. To discern the role of N-glycosylation in
modulating NapAB complex activity, we sought to investigate the ability to reduce
nitrate in C. jejuni and C. jejuni pglB::aphA and a newly constructed C. jejuni napA::aphA
mutant. The C. jejuni strains were grown in oxygen-limited conditions for 8 h. A biphasic
pattern of nitrite production was observed whereby nitrite production increases until
6 h and then starts to decline (Fig. 3B). After 1 h, a difference in nitrite production
between the wild type and its glycosylation-deﬁcient counterpart was observed, while
nitrite production in the C. jejuni napA::aphA mutant could not be detected (below the
limit of detection). At 6 h, C. jejuni pglB::aphA produced 63.7% (P 0.0018) less nitrite
than the wild type did (Fig. 3C). Our results indicate a potential correlation between
N-glycosylation and nitrate reductase activity in C. jejuni. It also suggests that despite
the increase in NapAB abundance in the glycosylation-deﬁcient strain, the activity of
the NapAB complex was severely impaired compared to its glycosylated counterpart.
These results indicate that N-glycosylation plays a role in enhancing NapAB complex
efﬁciency in nitrite production.
Disruption of N-glycosylation causes alterations in the isoprenoid biosynthetic
pathway and cell morphology abnormalities. Isoprenoids are one of the largest
naturally occurring organic compounds that are essential for maintaining bacterial cell
physiology (29). They are synthesized from a ﬁve-carbon universal precursor, isopentyl
diphosphate (IPP) or its isomer dimethylallyl diphosphate (DMAPP) (30). In C. jejuni, IPP
is produced exclusively via 2C-methyl-D-erythriotol 4-phosphate (MEP) pathway that
requires eight enzymatic steps. Our quantitative proteomic results show a signiﬁcant
reduction in MEP pathway enzymes in glycosylation-deﬁcient C. jejuni compared to the
wild-type strain (Fig. 4A). Interestingly, a 47% reduction in UppS abundance was
observed in C. jejuni pglB::aphA compared to its wild-type counterpart. UppS catalyzes
the sequential addition of IPP with farnesyl diphosphate to yield undecaprenyl diphos-
phate (Und-PP) (30). Und-P is an essential lipid carrier that plays a key role in the
biosynthesis of lipooligosaccharide (LOS), capsular polysaccharide (CPS), N-linked gly-
can, and peptidoglycan in C. jejuni (31). The low abundance of UppS was accompanied
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by an alteration in the cell morphology of glycosylation-deﬁcient C. jejuni, when
examined via scanning electron microscopy (SEM).
C. jejuni has a helical cell morphology that along with the polar ﬂagella, facilitates
the corkscrew motility in viscous media, giving it an advantage over other bacteria (32).
It has been postulated that the helical cell shape is critical for C. jejuni pathogenicity
(33). Interestingly, glycosylation-deﬁcient C. jejuni cells were shown to adapt a rod
shape and are more ﬂattened compared to the natural helical cell morphology of
wild-type C. jejuni (Fig. 4D and E). We also noted a nonuniformity among the cell length
in glycosylation-deﬁcient C. jejuni that is not evident in the wild type (Fig. 4B and C).
This might be due to the disruption of N-glycosylation in C. jejuni which also led to an
alteration in Und-PP production, as shown by the reduction in isoprenoid biosynthesis
FIG 3 Differential expression and functional analysis of NapAB complex in C. jejuni. (A) Differential expression of NapAB, TatA, and NapD in C. jejuni and C. jejuni
pglB::aphA. Data are from three biological replicates, and error bars represent standard deviations. Data were analyzed by Student’s t test. (B) Nitrate reduction
in C. jejuni strains. Ninety milliliters of brucella broth supplemented with 200 mM nitrate was inoculated separately with wild-type C. jejuni (black circles), C. jejuni
pglB::aphA (gray squares), and C. jejuni napA::aphA (blue circles) to an OD600 of 0.1 from an overnight culture. Cultures were incubated statically in a VAIN at
37°C. Samples were withdrawn every hour, C. jejuni cells were removed by centrifugation, and nitrate reduction was measured straight from the supernatant
against nitrite standards. (B) Nitrite accumulation in the supernatant over 7 h. (C) Nitrite accumulation in the supernatant at 6 h. The data represents the mean
of three biological replicates and two technical replicates, and error bars represent standard deviations. Signiﬁcance was calculated using one-way ANOVA test
with multiple comparison. ****, P  0.0001.
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and UppS, hence affecting PG biosynthesis in the cell. Our results show that
N-glycosylation plays an important role in maintaining cell physiology as well as cellular
morphology.
Role of N-glycosylation in host-pathogen interaction. To determine the impact
of protein glycosylation in host-pathogen interaction, we conducted chicken coloniza-
tion experiments. Owing to its prevalence in chicken and other avian species, many
reports have used chicken models of infection to test the effects of mutations in C.
jejuni (9, 34). We have previously reported that disruption of pglH substantially reduced
colonization in 2-week-old Light Sussex chickens (9). The glycosyltransferase PglH
catalyzes the addition of three 1,4- GalNAc to GalNAc-1,4-GalNAc-1,3-diBacNAc-1,
an important step in the production of the heptasaccharide. Proteins from C. jejuni
pglH::aphA can still be glycosylated by the truncated heptasaccharide (GalNAc-1,4-
GalNAc-1,3-diBacNAc-1). To understand the role of glycosylation in chicken coloni-
zation, we sought to investigate the impact of a C. jejuni pglB mutant devoid of the
ability to fully glycosylate proteins and compare it to the wild type. We separately
inoculated groups of twenty 2-week-old Campylobacter-free White Leghorn chickens
with 106 CFU of wild-type strain of C. jejuni or the pglB::aph mutant (Fig. 5A). Ten
chickens from each group were sacriﬁced at day 6 or 13 postinoculation, and viable C.
jejuni in the ceca (a key site of persistence) were enumerated postmortem.
Glycosylation-deﬁcient C. jejuni pglB::aph showed a six-log10-unit reduction in cecal
colonization compared to the wild type at day 6 (P 0.0001) and day 13 (P 0.0001)
(Fig. 5B and C). This reduction in colonization is in agreement with our previous work
on C. jejuni pglH::aphA. However, while glycan truncation in C. jejuni pglH::aphA reduced
chicken colonization (9), the complete abolishment of glycosylation in C. jejuni pglB::
aphA had a more severe impact on chicken colonization. The data highlight the
importance of glycosylation in Campylobacter survival in the avian reservoir primarily
responsible for zoonotic infections.
FIG 4 Abundance of undecaprenyl phosphate biosynthetic enzymes and cell morphology in C. jejuni strains. (A) Differential expression of MEP pathway
enzymes and UppS. Data are from three biological replicates, and error bars represent standard deviations. Data were analyzed by Student’s t test. *, P  0.05;
**, P  0.01; ***, P  0.001. (B to E) Scanning electron micrographs of wild-type C. jejuni 11168H (B) and C. jejuni 11168H pglB::aphA (C) and of a single bacterial
cell of wild-type C. jejuni 11168H (D) and a single bacterial cell of C. jejuni 11168H pglB::aphA (E). The bars represent 1.0 m.
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FIG 5 Colonization of C. jejuni and C. jejuni pglB::aphA in 17-day-old White Leghorn chickens. (A) Schematic diagram of the chicken colonization
experiment. Seventeen-day-old chicken were inoculated with 100 l of 106 CFU of wild-type C. jejuni or C. jejuni pglB::aphA. Chickens were then
(Continued on next page)
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DISCUSSION
Our results provide in-depth analyses on the alteration of the C. jejuni proteome as
a consequence of disrupting the N-linked protein glycosylation pathway. Loss of
glycosylation predominantly has a mass effect on the C. jejuni proteome, rather than
being restricted exclusively to glyco-modiﬁed proteins. Previous studies have reported
that loss of glycosylation affects bacterial motility and virulence (4, 35). However, none
of these studies investigated the relative quantities of individual protein(s) and their
function(s). Our TMT LC-MS/MS strategy shows that disruption of N-linked glycosylation
correlates with a marked increase in the abundance of not only periplasmic but also
cytoplasmic chaperones and proteases likely to be involved in folding, disaggregation,
and degradation of proteins. These results suggest a critical defect in protein folding
that potentially impairs protein cellular function. Differential abundance of protein
quality control machineries was not translated into an obvious change in growth
kinetics or cell dry weight. The cell count of the C. jejuni pglB::aphA strain at an OD600
of 0.4 to 0.5 showed a twofold reduction compared to wild-type C. jejuni; however, both
strains had similar dry cell weights and growth kinetics (see Fig. S1 in the supplemental
material). The reason(s) why the cell count was reduced at this OD600 in glycosylation-
deﬁcient C. jejuni strains remains unclear. One explanation may involve the observed
reduction in the abundance of the cell division protein FtsZ (P 0.006) (Fig. 1A),
suggesting major cellular alterations upon abolishing N-linked glycosylation. Functional
analysis demonstrates that molecular assemblies and protein functions were statisti-
cally impaired in glycosylation-deﬁcient C. jejuni. We postulate that the difference in
extrusion kinetics of ethidium bromide in C. jejuni strains were dependent on the C.
jejuni heptasaccharide. While the abundance of CmeABC was similar in wild-type C.
jejuni and C. jejuni pglB::aphA, we observed a signiﬁcant impairment in ethidium
bromide extrusion in the glycosylation-deﬁcient strain, even when compared to the C.
jejuni cmeB::aphA. This might be due to a central role of glycans in stabilizing not only
CmeABC as the major multidrug efﬂux pump but also CmeDEF as a secondary pump
(36). Indeed, CmeE, a periplasmic fusion glycoprotein in C. jejuni (6), was signiﬁcantly
reduced in C. jejuni pglB::aphA (P  0.0001). The low abundance of CmeE suggests that
CmeDEF is inefﬁciently assembled, and therefore functionally impaired. By testing other
molecular assembly functions, we noticed a general role played by the C. jejuni
heptasaccharide. Notably, the high abundance in the protein level of NapAB in C. jejuni
pglB::aphA was not accompanied by an increase in the nitrate reduction function of the
complex, indicating a severe impairment in the function of NapAB resulting from the
loss of N-linked glycans. The critical effects caused by N-glycosylation disruption are
extended beyond cellular activities and the assembly of protein complexes. In C. jejuni,
various oligosaccharides such as LOS and CPS and N-linked glycan pathways compete
for the limited pool of Und-P. Disrupting N-glycosylation in C. jejuni (and other bacteria
with general glycosylation systems) may lead to a secondary effect such as sequester-
ing of Und-P so that it will not be readily available for other pathways such as
peptidoglycan biosynthesis, leading to the cell morphology alterations observed in C.
jejuni pglB::aphA. In similar studies, interruption of the biosynthesis of the O antigen in
Escherichia coli led to morphological abnormalities in cell shape (37). This phenotype
was rescued by overexpressing UppS to increase the pool of Und-P (37). Scrutiny of our
proteomic data shows a reduction in the abundance of UppS as well as MEP pathway
enzymes in glycosylation-deﬁcient C. jejuni. This suggests either a feedback loop
mechanism that prevents the accumulation of Und-P intermediates, which might result
in cell toxicity, or perhaps a biophysical role played by N-linked glycans that affects cell
shape.
FIG 5 Legend (Continued)
sacriﬁced at day 6 and day 13, and postmortem examination (PM) was carried out by directly enumerating C. jejuni on CCDA plates. (B) CFU counts
of C. jejuni strains on CCDA plates on day 6 postinoculation. (C) Percentage of C. jejuni strains colonization on day 6 postinoculation. (D) CFU counts
of C. jejuni strains on CCDA plates on day 13 postinoculation. (E) Percentage of C. jejuni strain colonization on day 13 postinoculation. Statistical
signiﬁcance was calculated using Mann-Whitney test. ****, P  0.0001.
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We performed reverse transcriptase PCR (RT-PCR) to rule out any polar effects resulting
from disrupting pglB. Thus, transcription of the pglA and pglC genes downstream of pglB
were similar in both wild-type and glycosylation-deﬁcient C. jejuni (Fig. S2). Our results
show a dramatic decrease in chicken colonization with C. jejuni pglB::aphA exhibiting a
far greater decrease than that previously reported for C. jejuni pglH::aphA (9). This
means that in contrast to the C. jejuni pglH::aphA mutant where a truncated glycan is
produced, the full N-linked glycan is produced in the C. jejuni pglB::aphA strain but is not
transferred to the acceptor proteins. This observation provides deeper insight into the
essential role of the ﬁrst two or three monosaccharides (GalNAc-1,4-GalNAc-1,3-
diBacNAc) at the reducing end (which are absolutely conserved among strains in the
Campylobacter genus) (7, 38) in host-microbe interactions. This study adds to under-
standing of the biological role of this general N-linked glycosylation system. We present
a platform that enables the study of glycan-protein structural and functional relation-
ship and could be applied to other prokaryotic protein glycosylation systems. Efforts to
couple transcriptional and proteomic analysis to interrogate molecular changes result-
ing from altering or abolishing general glycosylation pathways in bacteria will enrich
our understanding of the evolution and emergence of protein posttranslational mod-
iﬁcations.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Campylobacter jejuni 11168H (39) and its derivatives, C.
jejuni pglB::aphA, C. jejuni cmeB::aphA, and C. jejuni napA::aphA, were used in this study. C. jejuni 11168H
was grown on Columbia-based agar or Mueller-Hinton-based agar supplemented with 5% horse blood
according to the manufacturer’s instructions. Campylobacter strains were grown at 37°C in a variable
atmospheric incubator (VAIN) cabinet (Don Whitley Scientiﬁc, UK) maintaining microaerophilic condi-
tions of 85% nitrogen, 5% oxygen, and 10% carbon dioxide.
Reverse transcriptase PCR. Overnight cultures of wild-type C. jejuni and C. jejuni pglB::aphA were
diluted to an OD600 of 0.1 and then incubated in the VAIN at 37°C under shaking conditions. At an OD600
of 0.4 to 0.5, cells were harvested, and RNA was extracted by using a Monarch total RNA extraction kit
(New England Biolabs) following the manufacturer’s protocol. The extracted RNA (2 g) was treated with
Ambion Turbo DNase (Invitrogen) according to the manufacturer’s instructions. cDNA was generated
using Superscript III kit (Invitrogen) from DNase-treated RNA. cDNA and DNase-treated RNA were used
as the templates in PCR using MyTaq mastermix (Bioline, UK) using the pglA, pglJ, and pglC oligonucle-
otide primers in Table 1.
Protein preparation and digestion. C. jejuni bacteria were grown overnight in brucella broth under
microaerophilic conditions at 37°C under shaking conditions at 75 rpm. The following day, 3.5 ml was
withdrawn to inoculate a 30-ml culture to a ﬁnal OD600 of 0.1. The cultures were then incubated as
described above until an OD600 of 0.4 to 0.5 was reached. Cells were harvested by centrifugation at
4,000 g for 45 min. Supernatant was discarded, and cells were resuspended in lysis buffer (7 M urea,
2 M thiourea, 5 mM DTT, and 2% [wt/vol] CHAPS) and ultrasonicated following the manufacturer’s
procedure for extraction of native protein samples from yeast cells (Covaris, US). Protein concentration
was then measured using Bradford reagant (Sigma, UK) following the manufacturer’s protocol and then
normalized to a total protein amount of 25 g for enzymatic digestion. Prior to enzymatic digestion and
labeling, samples were loaded into a stack gel for lysis buffer cleanup to eliminate any chemical
interference at the labeling stage and to compress the whole proteome into a single band. Sample
volumes were dried to half their original volume in a SpeedVac (Thermo Fisher Scientiﬁc, UK) with the
volume replaced by Laemmli buffer (2) and boiled for 10 min at 96°C. Reduced samples were loaded
on to a 10% BisTris NuPAGE gel (Invitrogen, UK) and resolved for 10 min (100 V; 59 mA; 6 W) to “stack”
the whole sample into a single band. Protein bands were visualized using Imperial protein stain (Thermo
Fisher Scientiﬁc, UK). Gel bands were then excised, chopped, washed with acetonitrile (ACN), dried, and
reduced by rehydration in 10 mM DTT for 30 min at 56°C. Gel slices were then washed with ACN, dried,
and alkylated by incubation in 55 mM IAA at ambient temperature for 20 min in the dark, followed by
washing with 100 mM TEAB, drying, and incubation in 40 l trypsin (1.25 g) at 37°C overnight. Peptides
were extracted by collecting reaction supernatant.
Peptide TMT labeling. Each sample was treated individually with labels added at a 1:1 ratio.
TMT6plex labels (Thermo Fisher Scientiﬁc, UK) were resuspended in 41 l ACN, vortexed, and centrifuged
for 1 min at 14,000 rpm. Each vial of TMT reagent was added to the appropriate sample, vortexed, and
brieﬂy centrifuged at 14,000 rpm before incubation at room temperature for 1 h. The reaction was
stopped by adding 8 l of 5% hydroxylamine (Sigma, UK) to each sample and incubated for a further 15
min at room temperature. Samples were then combined for each TMT6plex and incubated at room
temperature for 15 min, followed by freezing at –80°C and drying in a SpeedVac.
LC-MS/MS tandem mass spectrometry. The combined TMT-labeled peptide sample was resus-
pended in a solution containing water-acetonitrile-triﬂuoroacetic acid (98%:2%:0.05%) and analyzed by
LC-MS/MS. Chromatographic separations were performed using an Ultimate 3000 UHPLC system
(Thermo Fisher Scientiﬁc, UK). A 3-l injection of peptides (equivalent to 15 g peptides) was resolved
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by reversed phase chromatography on a 75-m C18 column (50 cm) using a three-step linear gradient of
acetonitrile in 0.1% formic acid. The gradient was designed to elute the peptides at a ﬂow rate of 250
nl/min over 120 min. The eluate was ionized by electrospray ionization using an Orbitrap Fusion Lumos
mass spectrometer (Thermo Fisher Scientiﬁc, UK) and Xcalibur v4.1 software. The instrument was
programmed to acquire data in the automated data-dependent switching mode, selecting precursor ions
based on their intensity for sequencing by higher-energy C-trap dissociation (HCD) for peptide identi-
ﬁcation and reporter ion fragmentation. Selection of precursor ions was based on their intensity for
sequencing by HCD in a TopN method. The MS/MS analyses were conducted using higher than normal
collision energy proﬁles that were chosen based on the mass-to-charge ratio (m/z) and the charge state
of the peptide. To increase fragmented peptide coverage and reporter ion intensities, a further synchro-
nous precursor scan (SPS) of the top ﬁve most intense peaks using MS3 was performed.
Raw mass spectrometry data were processed into peak list ﬁles using Proteome Discoverer (Thermo
Scientiﬁc; v2.2). The raw data ﬁle was processed and searched using the Mascot search algorithm (v2.6.0)
(Matrix Science, Boston, MA, USA) and the Sequest search algorithm against the current Campylobacter
jejuni 11168 proteome curated within Uniprot. Following processing with Proteome Discoverer, the
resulting ﬁle was exported into Perseus (v1.6.1) (http://www.perseus-framework.org) for qualitative and
quantitative data analysis.
Construction of C. jejuni pglB::aphA, C. jejuni cmeB::aphA, and C. jejuni napA::aphA. Construction
of C. jejuni pglB::aphA was achieved by nonpolar insertion of the aphA gene into a unique restriction site
present in the pglB gene of the pUC18 plasmid generated from a random genomic library used in
sequencing C. jejuni 11168 (40). Brieﬂy, pUC18 was digested using PsiI in the pglB gene, and linearized
plasmid was then blunt ended using T4 DNA polymerase (Promega) according to the manufacturer’s
protocol. The antibiotic resistance gene aphA was ampliﬁed and cut with StuI and blunt end ligated to
the linearized plasmid. The construct was then electroporated in C. jejuni 11168H, and colonies were
selected on CBA supplemented with kanamycin (30 g/ml). Inactivation of cmeB in C. jejuni 11168H was
achieved using the method described by Pumbwe and Piddock (26). Brieﬂy, 1 kbp of cmeB was ampliﬁed
with Phusion polymerase (New England Biolabs, UK) by primers FWDcmeB and REVcmeB using C. jejuni
11168H genomic DNA as the template. The amplicon was cloned into pJET1.2 to give pRSA. In order to
disrupt the gene, the kanamycin resistance gene aphA was cloned in the middle of the cmeB fragment
to give pRSF. Construction of C. jejuni 11168H napA::aphA was achieved by amplifying the napA gene
with Phusion polymerase (New England Biolabs, UK) using primers FWDnapA and REVnapA using C. jejuni
11168H genomic DNA as the template. The amplicon was then ligated into pGEM T-easy to give pATT3,
which was transformed to E. coli dam dcm mutant. To disrupt napA, aphA was cut with BamHI from
pJWK30, blunt ended by CloneJET PCR cloning kit blunting enzyme (Thermo Fisher Scientiﬁc, UK), and
TABLE 1 Bacterial strains, plasmids, and oligonucleotide primers used in this study
Bacterial strain,
plasmid, or primer Description or sequence
Source or
reference
E. coli strains
DH10B F mcrA Δ(mrr-hsdRMS-mcrBC) 80dlacZΔM15 ΔlacX74 endA1 recA1 deoR
Δ(ara leu)7697 araD139 galU galK nupG rpsL 
New England Biolabs, UK
dam dcm mutant ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 mcrA dcm-6 hisG4 rfbD1
R(zgb210::Tn10) Tets endA1 rspL136 (Strr) dam13::Tn9 (Camr) xylA-5 mtl-1
thi-1 mcrB1 hsdR2
New England Biolabs, UK
C. jejuni strains
11168H pglB::aphA C. jejuni 11168H pglB is inactivated by aphA encoding kanamycin resistance cassette This study
11168H Hypermotile variant of C. jejuni 11168 9
11168H cmeB::aphA C. jejuni 11168H cmeB is inactivated by aphA encoding kanamycin resistance cassette This study
11168H napA::aphA C. jejuni 11168H napA is inactivated by aphA encoding kanamycin resistance cassette This study
Plasmids
pJMK30 aphA gene cloned in BamHI restriction site 41
pRSA cmeB amplicon cloned in pJET1.2 This study
pRSF aphA gene cloned in BamHI to inactivate cmeB in pRSA This study
pATT3 napA cloned in pJET1.2 This study
pATT3F aphA cloned in ClaI site inactivates napA in pATT3 This study
Oligonucleotides
FWDcmeB GACGTAATGAAGGAGAGCCA
REVcmeB CTGATCCACTCCAAGCTATG
FWDnapA ACCGCTATTGCAAGTGCTGCTAG
REVnapA GAAAGCGGACAAGTCGCATCC
RTFWDPglA ATG GGC AAA AAT TCC TTA TCG TTT
RTREVPglA GCT CGA CTA TAT CAC TTC TAG
RTFWDPglC CTC CGG TGA TTT TAA TCA CTG
RTREVPglC TTG CTT ACC CCA CTT CGT TT
RTFWD PglJ TTA GGA AGT GGT GGT GCT GA
RTREV PglJ AAA GCT ATG TCT TCA AGG GC
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then ligated to pATT3 that was previously cut by ClaI and blunt ended to give pATT3F. pRSF and pATT3F
were electroporated in C. jejuni 11168H, and colonies were selected on CBA supplemented with
kanamycin (30 g/ml). All insertional inactivation were checked by gene-speciﬁc and aphA-speciﬁc
primers.
Antibiotic sensitivity. C. jejuni 11168H was grown in suspension in Mueller-Hinton broth equivalent
to a 1.0 McFarland standard, and 100-l aliquots were spread plated on dry Mueller-Hinton agar plates
supplemented with 5% sheep blood (Oxoid, UK). The plates were left for 5 to 10 min to dry before the
antibiotic strip (Oxoid, UK) was added. The plates were incubated at 37°C overnight. The MIC was read
directly from the strip at the point where the zone of inhibition of bacterial growth intersected with the
antibiotic concentration on the strip.
Ethidium bromide accumulation assay. Bacterial cells were grown to mid-log phase (OD600 of 0.4
to 0.5). Cells were harvested, washed, and resuspended in 0.1 M sodium phosphate buffer (pH 7)
(previously incubated in the VAIN) to an OD600 of 0.2. Cells were then incubated in the VAIN for 15 min
at 37°C before a 100-l aliquot was withdrawn to indicate time zero. Ethidium bromide (Sigma, UK) was
added to a ﬁnal concentration of 2 g/ml, and ﬂuorescence was measured at 530 nm excitation and
600 nm emission using a plate reader (Molecular Devices M3 plate reader, USA).
Determination of the nitrite concentrations in the culture supernatants. Determining the nitrite
concentrations in the culture supernatants was done according to the method of Pittman et al. (25) with
slight modiﬁcations. Brieﬂy, an overnight culture of C. jejuni grown in brucella broth was diluted to an
OD600 of 0.1 in oxygen-limited condition. Samples were drawn every hour and centrifuged at 12,000 g
for 1 min. Supernatant was then diluted 1:5 with deionized water. Fifty microliters of diluted culture
supernatant was mixed with 850 l of 1% (wt/vol) sulfanilamide dissolved in 1 M HCl and 100 l of 0.02%
(wt/vol) naphthylethylenediamine. After 15 min, the absorbance at 540 nm was measured using a plate
reader (Molecular Devices M3 plate reader, USA), and nitrite concentrations were determined by
reference to a standard curve.
Scanning electron microscopy. C. jejuni cells were resuspended in PBS after being scraped from an
overnight culture grown on Columbia-based agar plate supplemented with blood and Skirrow supple-
ment. The bacterial suspension was then mixed with ﬁxing buffer (0.1 M sodium cacodylate buffer
containing 4% paraformaldehyde [pH 7.4]) and ﬁxed on polylysine-coated coverslips overnight at 4°C.
Samples were then washed twice for 10 min in 0.15 M sodium cacodylate buffer (pH 7.3) and then treated
for 1 h at room temperature with 1% osmium tetroxide in 0.15 M cacodylate phosphate buffer. Samples
were dehydrated in an ethanol series consisting of the following steps: 10 min in 10% ethanol, 30 min
in 70% ethanol, and three times in 100% ethanol (20 min each). The coverslips were then transferring to
100% ethanol in critical point drying holders and then critical point dried using carbon dioxide in a
Polaron E3000 critical point dryer with 3 ﬂushes over a 45-min soaking period. The coverslips were
mounted on stubs (TAAB, UK) with conductive carbon adhesive discs (TAAB), and samples were sputter
coated with gold in an Emitech K550 sputter coater (45 mA current, 2 min). The cells were viewed, and
images were recorded using a FEI Quanta 200 ﬁeld emission scanning electron microscope (FEI UK Ltd.)
operated at 10 to 20 kV in high vacuum mode.
Chicken colonization. All procedures were conducted under Home Ofﬁce project license PPL
60/4420, according to the requirements of the Animal (Scientiﬁc Procedures) Act 1986, with the approval
of the Ethical Review Committee of the Moredun Research Institute. A total of 40 White Leghorn
chickens, obtained on the day of hatch from a Home Ofﬁce licensed breeding establishment were used.
Chickens were housed in groups of 20 in colony cages under speciﬁc-pathogen-free conditions. Groups
contained female and male chickens, and the wings of the chickens were tagged for individual
identiﬁcation. Water and sterile irradiated feed based on vegetable protein (DBM Ltd., UK) was provided
ad libitum. Fresh fecal samples collected from the cages were plated onto mCCDA plates to conﬁrm the
absence of C. jejuni in the chickens. When the chickens were 2 weeks old, they were challenged with 106
CFU of C. jejuni 11168H or 11168H pglB::aphA in a volume of 100 l. At 1 and 2 weeks after challenge,
postmortem examinations of 10 birds from each group were performed. The contents of each cecum
from each bird were weighed and serially diluted in phosphate-buffered saline (PBS) and then plated on
mCCDA plates to enumerate viable Campylobacter per gram of cecal contents. Statistical analysis was
performed using the Mann-Whitney test in Graphpad Prism 7.
Data availability. The raw quantitative proteomic data have been deposited to the Proteome-
Xchange consortium (http://www.proteomexchange.org/) via the PRIDE partner repository with identiﬁer
PXD011452.
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ADDENDUM
While this article was in process, an article on a similar topic was published in
Molecular & Cellular Proteomics: Cain JA, et al. 2019. Proteomics reveals multiple
phenotypes associated with N-linked glycosylation in Campylobacter jejuni. Mol Cell
Proteomics 18:715–734. https://doi.org/10.1074/mcp.ra118.001199.
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